Ten Thoren, C <br/><br/>
Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer.  [electronic resource] 

 -  The European journal of health economics : HEPAC : health economics in prevention and care  Aug 2020 
 - 881-893 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1618-7601 
<br/><br/><label>Standard No.: </label>10.1007/s10198-020-01180-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Databases, Factual<br/>Drug Approval--methods<br/>Germany<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Technology Assessment, Biomedical